BOSTON SCIENTIFIC (BSX BE) stock market data APIs
€87.8613
-0.64(-0.7%)
as of October 24, 2025
Try our APIs with
free plan!
BOSTON SCIENTIFIC Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for BSX.BE.
Prev. Close
87.8613
Open
87.2172
High
87.2172
Low
87.8613
52 wk Range
76-102
Market Cap
51 948 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get BOSTON SCIENTIFIC data using free add-ons & libraries
Get BOSTON SCIENTIFIC Fundamental Data
BOSTON SCIENTIFIC Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-10-22
- EPS/Forecast: 0.71
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
BOSTON SCIENTIFIC News
New
Why Analysts Are Rethinking Boston Scientific’s Story After Strong Results and Strategic Moves
Boston Scientific stock is under fresh scrutiny as analysts adjust their price targets upward. The consensus figure is now $126.14, up from $124.53. This incremental rise reflects optimism fueled by s...
Should Boston Scientific’s (BSX) Upbeat Q3 Results and Raised Guidance Prompt Investor Action?
Boston Scientific reported third-quarter 2025 results that exceeded analyst expectations, with revenue rising to US$5.07 billion and net income increasing to US$755 million, supported by strong perfor...
BSX Q3 Deep Dive: WATCHMAN and Electrophysiology Drive Outperformance, Guidance Raised
Medical device company Boston Scientific (NYSE:BSX) announced better-than-expected revenue in Q3 CY2025, with sales up 20.3% year on year to $5.07 billion. Guidance for next quarter’s revenue was be...
WST Stock Up on Q3 Earnings Beat, EPS View Raised on Demand & FX Benefit
West Pharmaceutical Services, Inc. WST delivered adjusted third-quarter 2025 earnings per share (EPS) of $1.96, which moved up 5.9% year over year. The figure topped the Zacks Consensus Estimate by 17...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
